Q2 2015 Holdings
Filed 2015-08-14 | 69 holdings | $308.6K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-09-09) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avalanche Biotechnologies in | COM | 05337G107 | $244 | 15,000 | 0.1% |
| Neothetics Inc | COM | 64066G101 | $387 | 43,000 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $432 | 37,500 | 0.1% |
| Glaukos Corp(GKOS) | COM | 377322102 | $435 | 15,000 | 0.1% |
| Ocera Therapeutics Inc | COM | 67552A108 | $475 | 125,000 | 0.2% |
| Xoma Corp del | COM | 98419J107 | $485 | 125,000 | 0.2% |
| Biolase Inc | COM | 090911108 | $522 | 300,000 | 0.2% |
| Kindred Biosciences Inc | COM | 494577109 | $638 | 93,500 | 0.2% |
| Biocryst Pharmaceuticals(BCRX)A | COM | 09058V103 | $672 | 45,000 | 0.2% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $758 | 50,000 | 0.2% |
| Biodelivery Sciences Intl in(BDSIUSD)Call | COM | 09060J106 | $845 | 106,200 | 0.3% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $873 | 78,386 | 0.3% |
| Unilife Corp New | COM | 90478E103 | $968 | 450,000 | 0.3% |
| Ascendis Pharma A S(ASND)A | SPONDSORED ADR | 04351P101 | $1.1K | 63,739 | 0.4% |
| Adaptimmune Therapeutics PLC(ADAPY)A | SPONDS ADR | 00653A107 | $1.4K | 76,850 | 0.5% |
| Versartis Inc | COM | 92529L102 | $1.5K | 100,000 | 0.5% |
| Radius Health Inc | COM NEW | 750469207 | $1.7K | 25,000 | 0.5% |
| Tonix Pharmaceuticals Hldg C | COM NEW | 890260201 | $1.8K | 202,500 | 0.6% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $2.0K | 17,500 | 0.7% |
| Sage Therapeutics Inc(SG7)Call | COM | 78667J108 | $2.3K | 31,700 | 0.7% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $2.4K | 300,000 | 0.8% |
| Avalanche Biotechnologies inCall | COM | 05337G107 | $2.4K | 150,000 | 0.8% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.6K | 250,000 | 0.8% |
| Axovant Sciences LTD | COM | G0750W104 | $2.8K | 135,000 | 0.9% |
| Therapeuticsmd Inc | COM | 88338N107 | $3.1K | 400,000 | 1.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $3.2K | 350,000 | 1.0% |
| Kempharm Inc | COM | 488445107 | $3.2K | 175,000 | 1.0% |
| Rockwell MED IncCall | COM | 774374102 | $3.2K | 200,000 | 1.0% |
| Anthem Inc(ELV) | COM | 036752103 | $3.3K | 20,000 | 1.1% |
| Assembly Biosciences Inc | COM | 045396108 | $3.4K | 175,000 | 1.1% |
| Genocea Biosciences Inc | COM | 372427104 | $3.7K | 270,000 | 1.2% |
| Sunesis Pharmaceuticals Inc | COM NEW | 867328601 | $3.8K | 1,250,000 | 1.2% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $3.9K | 75,000 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $3.9K | 600,000 | 1.3% |
| Wright MED Group Inc | COM | 98235T107 | $3.9K | 150,000 | 1.3% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $4.2K | 289,200 | 1.3% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.2K | 57,500 | 1.4% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $4.2K | 350,000 | 1.4% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $4.3K | 262,696 | 1.4% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $4.4K | 150,000 | 1.4% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $4.4K | 350,000 | 1.4% |
| Cellectis S A(CLLS)A | SPONSORED ADS | 15117K103 | $4.5K | 125,000 | 1.5% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $4.8K | 100,000 | 1.6% |
| Endochoice Hldgs Inc | COM | 29272U103 | $4.9K | 300,000 | 1.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $5.0K | 185,000 | 1.6% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $5.0K | 65,000 | 1.6% |
| Aetna Inc New | COM | 00817Y108 | $5.1K | 40,000 | 1.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.2K | 65,000 | 1.7% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $5.3K | 100,000 | 1.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.3K | 375,000 | 1.7% |